Cargando…
HUMORAL IMMUNITY IN PATIENTS WITH SARS-COV-2 INFECTION: A REVIEW
The COVID-19 pandemic caused by SARS-CoV-2 started in China in December, 2019 and has spread across several continents. As at 5th December, 2020, there have been 65,257,767 confirmed cases of COVID-19 worldwide with 1,513,179 deaths (2.31% mortality) Humoral immune responses are highly specific and...
Autor principal: | Ogundipe, H.D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Association of Resident Doctors (ARD), University College Hospital, Ibadan
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8791411/ https://www.ncbi.nlm.nih.gov/pubmed/35095374 |
Ejemplares similares
-
SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS-2 (SARS-COV-2) INFECTION: AN EPIDEMIOLOGICAL REVIEW
por: Buowari, D.Y., et al.
Publicado: (2021) -
Protective humoral immunity in SARS-CoV-2 infected pediatric patients
por: Zhang, Yaguang, et al.
Publicado: (2020) -
Humoral Immune Response to SARS-CoV-2 in Iceland
por: Gudbjartsson, Daniel F., et al.
Publicado: (2020) -
Realization of humoral immunity against SARS-CoV-2 infections
por: Lin, Yong, et al.
Publicado: (2021) -
Humoral immune response to SARS-CoV-2 in pregnant and nonpregnant women following infection
por: Jacobs, Marni B., et al.
Publicado: (2023)